Kyras Therapeutics
New York
About Kyras Therapeutics
Kyras Therapeutics is a biotech company. According to data from the National Cancer Institute, more than 30 percent of all human cancers are driven by mutations in RAS genes, including 95% of pancreatic, 45% of colorectal, and 35% of lung cancers, among many others.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2015)
- Website: kyrasrx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/kyras-therapeutics-3335201 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.